At a glance
- Originator Eli Lilly
- Class Anorectics; Cyclohexanes; Piperidines; Small molecules
- Mechanism of Action Opioid delta receptor antagonists; Opioid kappa receptor antagonists; Opioid mu receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 10 Nov 1995 Discontinued-Preclinical for Obesity in USA (Unknown route)